Anterogen.Co.Ltd (065660) - Total Liabilities

Latest as of September 2025: ₩1.40 Billion KRW ≈ $951.49K USD

Based on the latest financial reports, Anterogen.Co.Ltd (065660) has total liabilities worth ₩1.40 Billion KRW (≈ $951.49K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 065660 net assets growth trend to track the company's year-over-year net asset growth rate.

Anterogen.Co.Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Anterogen.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Anterogen.Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.

Anterogen.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Anterogen.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Afluente Transmissão de Energia Elétrica S.A SA:AFLT3	Brazil	R$112.60 Million
Adda Corporation TWO:3071	Taiwan	NT$1.95 Billion
Insumos Agroquimicos SA BA:INAG	Argentina	AR$39.89 Billion
CastleNet Technology TWO:8059	Taiwan	NT$7.28 Billion
Taiwan Chelic Corp Ltd TW:4555	Taiwan	NT$1.55 Billion
Overseas Commerce Ltd TA:OVRS	Israel	ILA446.32 Million
Lee Ku Ind KO:025820	Korea	₩231.33 Billion
ÖKOWORLD AG XETRA:VVV3	Germany	€24.57 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Anterogen.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Anterogen.Co.Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	41.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anterogen.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual total liabilities of Anterogen.Co.Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.87 Billion ≈ $3.98 Million	-70.65%
2023-12-31	₩19.99 Billion ≈ $13.54 Million	+15.25%
2022-12-31	₩17.34 Billion ≈ $11.75 Million	-12.57%
2021-12-31	₩19.83 Billion ≈ $13.44 Million	+50.98%
2020-12-31	₩13.14 Billion ≈ $8.90 Million	-18.91%
2019-12-31	₩16.20 Billion ≈ $10.98 Million	-64.29%
2018-12-31	₩45.37 Billion ≈ $30.75 Million	+293.48%
2017-12-31	₩11.53 Billion ≈ $7.81 Million	+721.17%
2016-12-31	₩1.40 Billion ≈ $951.53K	-24.04%
2015-12-31	₩1.85 Billion ≈ $1.25 Million	+22.79%
2014-12-31	₩1.51 Billion ≈ $1.02 Million	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$88.56 Million

₩130.68 Billion KRW

Market Cap Rank

#19555 Global

#951 in Korea

Share Price

₩16430.00

Change (1 day)

+10.05%

52-Week Range

₩14930.00 - ₩58000.00

All Time High

₩197700.00